Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (13019)	8/11/1998 12:56:00 AM
From: VLAD	Read Replies (1) \| Respond to of 23519

Alien, Are you still in love with CEPH? Trailing earnings of over -$2.00 along with 2 drugs that do not have a very large patient base does not appear all that attractive to me. BTW, what is the latest story regarding the FDA and Myotrophin. This is a good example of just how political the FDA really is. They give CEPH the red light on a drug that may help but certainly would not hurt terminally ill patients yet they have no problem fast tracking Viagra and continue to view the Viagra linked deaths through their rose colored glasses or shall I say the diamond studded glasses given to them by Pfizer. Its enough to make me wanna puke!!